Keyphrases
Adjuvant Therapy
5%
Antitumor Immune Response
11%
Argon
5%
Attack Target
11%
Cancer Center
5%
Cancer Therapy
5%
Carcinogen
5%
Clinical Trial Development
5%
Clinically Significant
5%
Coin Flip
11%
Collagen
16%
Collagen Binding
33%
Combination Immunotherapy
11%
Combined Method
5%
Cryo
22%
Cryoablation
66%
Cryoimmunotherapy
100%
Cryoprobe
5%
Current Treatment
5%
Defense Mechanisms
5%
Early-stage Lung Cancer
11%
Effective Therapy
5%
Effector Immune Cells
11%
High Risk
5%
Hospital Stay
5%
Humanized
5%
Immune Cells
16%
Immune Response
5%
Immune Stimulation
11%
Immune System
16%
Innovative Strategies
11%
Interleukin
5%
Interleukin-12 (IL-12)
50%
Large Animal Model
5%
Left behind
5%
Liquefied Gas
11%
Liquefied Nitrogen
11%
Locoregional Therapy
11%
Lung Cancer
27%
Lung Cancer Cells
5%
Lung Cancer Patients
11%
Lung Cancer Treatment
5%
Lung Metastasis
5%
Lung Tumor
22%
Master Regulator
5%
Medical Center
5%
Metastasis
11%
Military Personnel
5%
Military Veterans
5%
Minimally Invasive
5%
Novel Molecules
11%
Occupational Exposure
5%
Patient Recovery
11%
Patient's Will
5%
Patrolling
11%
Primary Tumor
11%
Protein Fragments
5%
Recurrence Prevention
11%
Recurrent Tumor
11%
Smoking Exposure
11%
Stage I Disease
11%
State Colleges
5%
Structural Proteins
5%
Suppressing Cell
11%
Surgical Alternative
11%
Surgical Removal
5%
Surgical Resection
11%
Survival Rate
5%
Systemic Antitumor Immunity
11%
Systemic Circulation
11%
Translational Studies
5%
Treatment Strategy
5%
Tumor
16%
Tumor Cells
16%
Tumor Model
5%
Tumor Recurrence
5%
Veterinary Medicine
5%
Medicine and Dentistry
Adjuvant Therapy
5%
Cancer Cell
5%
Cancer Therapy
5%
Carcinogen
5%
Cells of the Immune System
5%
Clinical Trial
5%
Cryoablation
66%
Disease
5%
Immune Response
11%
Immune System
11%
Immunocompetent Cell
22%
Immunotherapy
27%
Interleukin 12
50%
Interleukin Derivative
5%
Lung Cancer
50%
Lung Tumor
22%
Malignant Neoplasm
5%
Medicine
5%
Metastatic Carcinoma
16%
Neoplasm
16%
Occupational Exposure
5%
Primary Tumor
11%
Recurrent Disease
11%
Structural Protein
5%
Surgery
11%
Survival Rate
5%
Systemic Circulation
11%
Treatment of Lung Cancer
11%
Tumor Cell
16%
Tumor Model
5%
Tumor Recurrence
22%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogen
5%
Clinical Trial
5%
Disease
5%
Immunotherapy
25%
Interleukin 12
50%
Interleukin Derivative
10%
Lung Cancer
50%
Lung Tumor
20%
Malignant Neoplasm
10%
Metastasis
5%
Neoplasm
30%
Occupational Exposure
5%
Primary Tumor
10%
Recurrent Disease
10%
Structural Protein
5%
Survival Rate
5%
Systemic Circulation
10%
Tumor Model
5%
Tumor Recurrence
10%